Objective Fear of cancer recurrence is an important clinical phenomenon and is associated with decrements in life domains. The study goals were to characterize patterns of global fear of recurrence (FOR) and 4 domains of fear (health, role, womanhood, and death worry) over time in women who were diagnosed with gynecological cancer and to identify demographic, medical, and psychological predictors of FOR.
| INTRODUCTION
Fear of recurrence (FOR) is a pervasive concern among cancer patients.
1,2 Fear of recurrence encompasses a variety of illness-related fears and is defined as the fear that cancer will recur, progress, or metastasize in the same or another part of the body. 3, 4 There is a large quantity of literature suggesting that between 17% and 72% of cancer patients report elevated levels of FOR [5] [6] [7] and persist in a subgroup of survivors. 8 Evidence suggests that elevated levels of FOR persist among a subgroup of cancer survivors many years after treatment has been completed. 8 Because of the large percentage of patients who experience it, FOR may be considered a normal response to the experience of a life-threatening illness such as cancer.
| The course of FOR over the cancer trajectory
The majority of longitudinal studies suggest that FOR declines among the majority of cancer patients in the first year after diagnosis. [9] [10] [11] However, its course is highly variable, with individual differences over time. 12, 13 Some patients' FOR remains stable, with consistently elevated, consistently moderate, or consistently low levels of fear.
2,10,14
| FOR as a multidimensional construct
Although FOR has consistently been associated with distress and lower quality of life, 15, 16 there has been less attention given to its complexity. Two conceptualizations of FOR 15, 16 propose that it is a multidimensional construct. These formulations illuminate the nature of fears and illuminate what aspects about possibility of recurrence or progression of cancer cause fear. Thus, global fears are "unpacked"
or separated into the domains of life and future events (eg, death) that contribute to the fear experience. These domains may include fear about the impact of recurrence on sexuality and romantic relationships, concerns about the possibility of future medical treatments, concerns about the impact of future emotional upset, fear about being able to fulfill work and home responsibilities, and worry about the possibility of death. 16 By considering FOR as a multidimensional construct, the complexity of this construct can be more fully understood.
| Correlates and predictors of FOR
Cross-sectional studies have indicated that FOR is associated with lower mental, physical, and social aspects of quality of life, 7,17 greater health care utilization, 18 anxiety, 5 depressive symptoms, 19 and intrusive thoughts. 12, 20 Longitudinal studies have suggested that demographic, medical, and psychological factors contribute to increases or decreases in FOR over time. Younger age, 21 lower socioeconomic status, 10 advanced disease, 2 elevated initial depression, 10 and elevated anxiety 12 are associated with elevated FOR. 10 In addition, less social support and more negative social interactions have been associated with higher FOR over time. 10 Holding back sharing concerns is associated with elevated FOR in cross-sectional research. 13, 22 While coping strategies have been emphasized to a lesser degree in the literature, 1 study does suggest that lower coping self-efficacy is associated with elevated FOR among breast cancer survivors. 13 
| The present study
Most longitudinal studies describe average changes in FOR over time.
These analyses are useful, but more can be learned by identifying subgroups of women who exhibit common patterns of change over 26 Between one-fifth and one-half of women with these cancers report elevated FOR. 27, 28 We proposed that there would be varying patterns of FOR with stable, increasing, and decreasing patterns. We proposed 2 possible trajectories: the majority of participants' FOR would decline over the 6-month period after diagnosis, 10 but there would be a group who was characterized by persistently elevated FOR.
The second goal was to evaluate the demographic, medical, and psychological factors associated with FOR trajectory subgroups. We predicted that being younger, being diagnosed with more advanced disease, and reporting greater baseline physical impairment would characterize the group of patients reporting persistently elevated FOR. We evaluated 3 categories of factors: distress, cancer-related coping strategies and cancer-related coping efficacy, and difficulties with one's social network. We proposed that women with persistently elevated FOR would have higher baseline depression and cancer-specific distress. Based on theories regarding coping with traumatic events, 29 we proposed that approach-oriented coping strategies (positive reappraisal, problem-solving, and expressing emotions) and greater coping self-efficacy would predict declines in FOR over time.
We proposed that women who reported less holding back sharing concerns and fewer unsupportive responses would evidence declines in FOR over time. There has been little work that has evaluated variables associated with group-based trajectories of FOR, making it difficult to specify further the expected relationships of variables with global FOR and its domains over time. Comparisons between study participants and refusers of the parent study indicated that participants were younger (t 1028 = 3.3, P < .01, M participants = 56.4, M refusers = 60.3 years) and diagnosed more recently (t 1023 = 2.9, P < .01, M participants = 3.9, M refusers = 4.5 months).
The acceptance rate was significantly higher at 2 sites than at the other 4 sites (χ 
| Cancer-specific distress
The Impact of Events Scale 31 is a 15-item measure of intrusive thoughts, avoidance, and numbing. Internal consistency was 0.89.
| Positive reappraisal and planful problem-solving
Four items assessed positive reappraisal coping and 4 items assessed problem-solving. 32 Participants were asked to rate the ways they were coping with the cancer experience. Ratings ranged from 1 = Did not do this to 4 = Did this a lot. Internal consistency was 0.88.
| Emotional expressivity
Emotional expressivity is a measure of a person's general tendency to express emotions. This construct was assessed using the Emotional Expressivity Questionnaire, which is a 16-item scale measuring the level of comfort with expressing emotions 
| Holding back sharing concerns with family and friends
Holding back sharing concerns was assessed by using a previously developed measure, 35 which is 12 cancer concerns rated on a 6-point scale (0 = not at all to 5 = a lot). Higher scores indicate more holding back sharing. Because participants did not rate holding back sharing concerns if they did not report having a concern, an average was used in the analysis. 
| Perceived unsupportive responses from family and friends

| Physical impairment
The 26-item physical limitations subscale of the Cancer Rehabilitation Evaluation System 37 assesses difficulty completing daily tasks and activities. Participants rated impairment during the past month from 0 (not at all) to 4 (very much). Internal consistency was 0.92.
| Medical status
A medical chart review was used to capture primary cancer diagnosis, disease stage, metastatic status, treatments received (surgery, chemotherapy, and/or radiation), and time since diagnosis. For the analyses, the number of treatments received was entered into the equation rather than the treatments received. As can be seen in Table 1 , the majority received surgery and chemotherapy. Thus, categorizing treatments received would not yield meaningful results.
| Analytic approach
The PROC TRAJ procedure in SAS (version 9.4) was used to conduct a group-based trajectory modeling approach, which is a specialized application of finite mixture modeling. 38 In a nontechnical sense, this approach is a combination of multilevel growth modeling and cluster analysis in that it is designed to identify subgroups of individuals who show similar trajectories on an outcome over time. Time was coded such that a 1 unit change corresponded to a 1-month increase, and because each woman completed and returned the questionnaires at somewhat different times in spite of the fact that questionnaires were sent at 5 and 9 weeks and again at 6 months, we used the woman's date of questionnaire return as our measure of time. On average we received the questionnaires at 1.73, 2.86, and 6.35 months after baseline, which was coded as 0 months. Thus, the intercept refers to the initial assessment. Models were developed by sequentially testing 1, 2, 3, and 4 subgroup models, initially allowing for linear and quadratic fixed effects for time. However, because there were no significant quadratic effects, the final models only included intercepts and the linear effect of time. A common random intercept variance was specified across the subgroups, and maximum likelihood was used as the estimation method.
The PROC TRAJ procedure generates group membership classification for each participant in the study, and we used that information to examine the extent to which there were differences between the subgroups on demographic, medical, and psychological variables. With regard to group membership criteria, trajectories were labeled "stable"
when the linear effect was not significantly different from 0. Trajectories were labeled "increasing" when the beta was significantly different from 0 and the sign for the coefficient was positive. Trajectories were labeled "decreasing" when the beta was significantly different from 0 and the sign for the coefficient was negative.
We used SPSS version 22 to conduct analyses of variance (ANOVAs) on quantitative variables to assess mean differences across subgroups, and significant ANOVAs were followed-up using post hoc Tukey tests to correct for family-wise error. We used χ 2 tests to evaluate subgroup differences on categorical variables.
3 | RESULTS 3.1 | Descriptive information on the sample Table 1 contains characteristics of the sample. The majority was white (79%) and married (69%). The average age was 56.2 years (range, 24-80 years), and the majority of the sample was diagnosed with ovarian cancer (53%). Slightly less than half (41%) of the sample had metastatic cancer and were diagnosed with stage III disease (48.3%). The average time since diagnosis was 3.9 months. The majority had undergone surgery and were receiving chemotherapy at the time of the baseline survey. Table 2 contains information about global FOR and the 4 domains and the baseline predictors. we used ANOVA to test for subgroup differences. Although there were no significant associations between trajectory subgroups and income or marital status, age and ethnicity were related to the subgroups. Specifically, there were significant age differences for role worries and womanhood worries. Post hoc Tukey tests indicated that for role worries, women who were in the high-stable subgroup were significantly younger than women in the low-stable subgroup. Women in the middle group (moderate-decreasing) were not significantly different from those in the other subgroups. Likewise, women in the high-increasing subgroup for womanhood worries were younger than women in the low-decreasing subgroup. There were also associations between ethnicity (white/nonwhite) and both global FOR subgroups and health worries subgroups. For global FOR, nonwhite women were most likely to be in subgroup 1 (low-stable), but white women were most likely to be in subgroup 3 (high-stable). For health worries, both white and nonwhite women were more likely to be in the highdecreasing subgroup, but this tendency was especially strong for white women.
| Trajectory analysis results
We also tested for subgroup differences on medical variables.
Only functional impairment and metastatic status differed as a function of the subgroups. Differences in functional impairment were found for the role worry subgroups and the womanhood worry subgroups. Women in the high-stable (subgroup 3) for role worry reported significantly higher functional impairment than women in the low-stable subgroup. Similarly, women in the high-increasing womanhood worry subgroup (subgroup 2) reported significantly higher functional impairment than women in the low-decreasing womanhood worry subgroup. For metastatic status, there were significant subgroup differences for both global FOR and womanhood worries. The frequencies indicate that women without metastatic cancer were more likely to be in the low-stable global FOR subgroup and women with metastasized disease were more likely to be in the high-stable global FOR subgroup. The pattern for womanhood worries was somewhat different in that women with metastasized cancer were especially likely to be in the low-decreasing womanhood worry subgroup. Table 3 presents the means, standard deviations, and F tests assessing the extent to which women in the different subgroups for global FOR and the 3 worry variables differed in their initial psychological functioning and coping strategies. No significant differences between the subgroups were found for initial emotional expressiveness, problem-solving coping, or unsupportive responses from friends and family. These variables are not included in Table 3 and are available from the authors. There were significant differences for initial cancerspecific distress, depression, holding back sharing concerns, coping self-efficacy, and positive reappraisal coping.
As an overview of the pattern of results, in every case in which there were statistically significant mean differences across the subgroups, regardless of the outcome variable, the differences between the lowest fear subgroup (ie, subgroup 1 which was low-stable) and the highest fear subgroup (ie, generally high-stable or subgroup 3 for global FOR and role worries and subgroup 2 for health and womanhood worries) were significant. The middle subgroup for global FOR and role worries (ie, starts high-decreasing) generally did not differ from the high-stable subgroup. More specifically, women in the high- stable subgroup for global FOR (subgroup 3) were significantly higher in initial cancer-related distress and initial depression, and they reported holding back sharing concerns to a greater degree than women in the low-stable subgroup (subgroup 1). They also reported significantly lower initial coping efficacy. Similarly, women in the high-stable subgroup (subgroup 3) for role worry reported higher initial cancer-related distress, depression, and lower coping efficacy than women in the low-stable subgroup (1) . Women in the high-decreasing subgroup for health worries were significantly higher than the lowincreasing subgroup in initial cancer-related distress, depression, and holding back sharing concerns, and they were significantly lower in initial coping efficacy and positive reappraisal coping. Finally, women in the high-increasing womanhood worry subgroup were significantly higher in initial distress, depression, and holding back, and they were significantly lower in coping efficacy.
| DISCUSSION
To our knowledge, this study was the first to examine group trajectories of FOR and its domains across a 6-month period following initial A second notable finding was that a number of psychological, coping, and support network variables differentiated the subgroup trajectories, but many did not. The strongest differences between FOR trajectories were noted for initial depression and cancer-related distress, such that the high-stable trajectory group differed from the lowest trajectory groups. Notably, women in the high-stable group evidenced lower coping efficacy than women in the other 2 groups. Trajectories of global fear, role, worry, health worry, and womanhood worry (coefficients are in Table 1) cancer recurrence, which cannot be controlled or solved. Unsupportive responses may not be associated with FOR because our measure assessed critical or avoidant reactions surrounding the patient's cancer, but we did not specifically assess unsupportive reactions related to the disclosure of fears about cancer recurrence (eg, "Seemed uncomfortable talking to you about your illness" was assessed rather than "Seemed uncomfortable talking to you about your fears about cancer coming back").
Overall, these findings are consistent with cross-sectional and longitudinal research suggesting that depression is associated with global FOR 10, 12 and extends this work by suggesting that depression and cancer-specific distress are associated with fears about the impact of cancer progression on specific domains of life. Holding back sharing concerns has been associated with global FOR in our prior cross-sectional work 22 and has been consistently associated with psychological distress in a number of prior studies with patients dealing with other kinds of cancer. 35 As noted by Lepore, 29 sharing concerns may facilitate adaptation by providing the patient an opportunity to process her fears with others and allow others to help her challenge her negative beliefs about her future. Little attention has been paid to coping self-efficacy among women with gynecological cancer, but coping self-efficacy has been associated with lower global FOR among survivors of other types of cancer. 13, 39 This pattern suggests that improving patients' confidence that they can manage cancer stressors and assisting patients with sharing concerns may assist patients who endorse high levels of global FOR and role and womanhood worries. disease on their body image and sexuality because the impact on other areas of their lives is more significant. When functional impairment was examined, there were differences with regard to role and womanhood worries. Women in the high-stable role worry group reported higher initial functional impairment than women in the low-stable role worries group, and women in the high-increasing womanhood worry group reported higher functional impairment than women in the lowdecreasing womanhood worry group. Thus, women experiencing higher levels of initial physical impairment are more likely to report consistently elevated concerns about their abilities to fulfill their work and family responsibilities and possibly trigger worries about sexual functioning and body image.
There are several limitations to note. The first limitation is that the sample consisted of usual care participants from a randomized clinical trial. Thus, we did not conduct a population-based study assessing the natural course of FOR. Women participating in a psychotherapy trial may be more distressed and experience fewer fears about recurrence than women who decline participation. Therefore, the design used in this study may introduce important biases in our results, which may include regression to the mean and the effect of being in a clinical study. A second and related limitation is the participation rate (28.1%).
Although this participation rate is common for a psychotherapy trial, this rate is relatively low for an observational study. As noted above, women who decline an intervention study may be less distressed, Additionally, the cohort was a relatively small sample of mostly white, well-educated, and middle-class patients. Future research might focus on minority and less socioeconomically advantaged patients. Seventh, women who chose to participate were significantly younger and diagnosed more recently, and thus, it is possible that the age differences that emerged in regard to FOR reflected the fact that the sample was younger than the general population of women with gynecological cancers. Finally, there were limitations of our measures. Our measure of cancer-specific distress, the Impact of Events Scale, is a measure of subjective distress caused by a traumatic event (in this case, cancer).
Items assess intrusive thoughts and avoidance of distressing cancerrelated thoughts and feelings. However, this measure may not capture all aspects of cancer-related distress. In addition, the measure of depressive symptoms contains several items that assess somatic symptoms that may be associated with cancer treatment (eg, reduced appetite and fatigue) and thus may have some overlap with recurrence fears, particularly fears about health. General emotional expressivity was assessed in this study, rather than expression of feelings and fears about the cancer experience. Although we did assess holding back sharing cancer-related concerns, future studies may benefit from including the degree to which the patient expressed cancer-related fears to others.
In conclusion, group-based trajectory modeling was an effective 
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